AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
CIPROFLOXACIN HYDROCHLORIDE USP
18 registrations across 4 African markets— 14 active
Markets with CIPROFLOXACIN HYDROCHLORIDE USP
Recent registrations
| Brand / Product | Market | Holder | Status | Expires |
|---|---|---|---|---|
| CIPROQUIN-500 Film-Coated Tablet | 🇰🇪Kenya | KOPRAN LIMITED | active | Apr 2031 |
| CIPRICOM EYE/EAR DROPS OPHTHALMIC SOLUTION | 🇬🇭Ghana | — | active | Oct 2029 |
| CIPRICOM EYE/EAR DROPS OPHTHALMIC SOLUTION | 🇬🇭Ghana | — | active | Oct 2029 |
| CIPROKANT-500 Tablets | 🇷🇼Rwanda | S KANT HEALTHCARE LTD | active | Aug 2029 |
| CIPROLAB-500 TABLETS Tablets | 🇷🇼Rwanda | LABORATORY & ALLIED LTD | active | Aug 2029 |
| SHALCIP TABLETS | 🇬🇭Ghana | 30TH FLOOR, ALMAS TOWER, JUMEIRAH LAKE TOWERS - DUBAI - UNITED ARAB EMIRATES | active | Aug 2029 |
| SHALCIP TABLETS | 🇬🇭Ghana | 30TH FLOOR, ALMAS TOWER, JUMEIRAH LAKE TOWERS - DUBAI - UNITED ARAB EMIRATES | active | Aug 2029 |
| CIPROFLOXACIN HYDROCHLORIDE USP TABLETS | 🇷🇼Rwanda | GRACURE PHARMACEUTICALS LIMITED | active | Feb 2029 |
| CIPROGLAX TABLETS Tablet | 🇰🇪Kenya | GALAXY PHARMACEUTICAL LTD | active | Dec 2027 |
| NOVACIP EYE/EAR DROPS 0.3% W/V | 🇬🇭Ghana | — | active | Dec 2027 |
| NOVACIP EYE/EAR DROPS 0.3% W/V | 🇬🇭Ghana | — | active | Dec 2027 |
| CIPROLEX EYE/EAR DROP | 🇬🇭Ghana | — | active | Jun 2027 |
| CIPROLEX EYE/EAR DROP | 🇬🇭Ghana | — | active | Jun 2027 |
| CIPLUME Eye drops Anticoagulant And Preservative Solution For B | 🇰🇪Kenya | AXA Parenterals Ltd | active | Jan 2027 |
| CIPROFLOXACIN 500MG TABLET TABLET | 🇲🇼Malawi | — | expired | Jun 2014 |
| CIPRODAC 250MG TABLET TABLET | 🇲🇼Malawi | — | expired | Jun 2009 |
| CIPROFLOXACIN 500MG TABLET TABLET | 🇲🇼Malawi | — | expired | Jun 2008 |
| NEOCIP-250 250MG TABLET TABLET | 🇲🇼Malawi | — | expired | Jun 2007 |
CIPROFLOXACIN HYDROCHLORIDE USP in Africa — Regulatory Overview
CIPROFLOXACIN HYDROCHLORIDE USP is registered across 4 African markets with 18 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Ghana, Malawi, Kenya, Rwanda. AfricaRegulatory refreshes this data daily from official government sources.
Of the 18 registrations, 14 (78%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.